Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), Section of Pharmacology and Toxicology, University of Florence, Italy.
Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), Section of Pharmacology and Toxicology, University of Florence, Italy.
Biochem Pharmacol. 2020 Jul;177:113956. doi: 10.1016/j.bcp.2020.113956. Epub 2020 Apr 3.
Oligodendrocytes are the only myelinating cells in the brain and differentiate from their progenitors (OPCs) throughout adult life. However, this process fails in demyelinating pathologies. Adenosine is emerging as an important player in OPC differentiation and we recently demonstrated that adenosine A receptors inhibit cell maturation by reducing voltage-dependent K currents. No data are available to date about the A receptor (AR) subtype. The bioactive lipid mediator sphingosine-1-phosphate (S1P) and its receptors (S1P) are also crucial modulators of OPC development. An interaction between this pathway and the AR is reported in peripheral cells. We studied the role of ARs in modulating K currents and cell differentiation in OPC cultures and we investigated a possible interplay with S1P signaling. Our data indicate that the AR agonist BAY60-6583 and its new analogue P453 inhibit K currents in cultured OPC and the effect was prevented by the AR antagonist MRS1706, by K channel blockers and was differently modulated by the S1P analogue FTY720-P. An acute (10 min) exposure of OPCs to BAY60-6583 also increased the phosphorylated form of sphingosine kinase 1 (SphK1). A chronic (7 days) treatment with the same agonist decreased OPC differentiation whereas SphK1/2 inhibition exerted the opposite effect. Furthermore, AR was overexpressed during OPC differentiation, an effect prevented by the pan SphK1/2 inhibitor VPC69047. Finally, AR silenced cells showed increased cell maturation, decreased SphK1 expression and enhanced S1P lyase levels. We conclude that ARs inhibit K currents and cell differentiation and positively modulate S1P synthesis in cultured OPCs.
少突胶质细胞是大脑中唯一的髓鞘形成细胞,它们在成年期从其前体细胞(OPC)分化而来。然而,这一过程在脱髓鞘病变中失败。腺苷作为 OPC 分化的重要参与者正在出现,我们最近证明,腺苷 A 受体通过减少电压依赖性 K 电流来抑制细胞成熟。迄今为止,尚无关于 A 受体(AR)亚型的可用数据。生物活性脂质介质 1-磷酸鞘氨醇(S1P)及其受体(S1P)也是 OPC 发育的关键调节剂。该途径与 AR 之间的相互作用在周围细胞中已有报道。我们研究了 AR 在调节 OPC 培养物中的 K 电流和细胞分化中的作用,并研究了与 S1P 信号转导的可能相互作用。我们的数据表明,AR 激动剂 BAY60-6583 及其新型类似物 P453 抑制培养的 OPC 中的 K 电流,该作用可被 AR 拮抗剂 MRS1706、K 通道阻滞剂阻断,并且可被 S1P 类似物 FTY720-P 以不同方式调节。OPC 急性(10 分钟)暴露于 BAY60-6583 也增加了鞘氨醇激酶 1(SphK1)的磷酸化形式。用相同的激动剂进行慢性(7 天)处理会减少 OPC 的分化,而 SphK1/2 抑制则产生相反的效果。此外,AR 在 OPC 分化过程中过表达,该作用可被泛 SphK1/2 抑制剂 VPC69047 阻止。最后,沉默 AR 的细胞显示出更高的细胞成熟度、更低的 SphK1 表达和增强的 S1P 裂解酶水平。我们得出结论,AR 抑制 K 电流和细胞分化,并在培养的 OPC 中正向调节 S1P 合成。